Description

6,7-Dihydro-4,10,11-Trimethoxy-7-Methyl-5H-Benzo[G]-1,3-Benzodioxolo[6,5,4-De]Quinoline is a complex, polycyclic alkaloid derivative of significant interest in advanced organic synthesis and pharmaceutical research. This compound matters as a sophisticated chemical building block for developing novel bioactive molecules, particularly in medicinal chemistry. Researchers and development chemists in the pharmaceutical, agrochemical, and fine chemical industries require this high-purity intermediate for creating new drug candidates and specialized materials.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of novel alkaloid-based drug candidates targeting central nervous system (CNS) disorders.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies to optimize potency and selectivity of new therapeutic agents.
• Reference Standard: Employed as a high-purity analytical standard in quality control laboratories for method development and compound identification.
• Biochemical Tool Compound: Utilized in pharmacological research to study specific receptor interactions and enzyme inhibition mechanisms.
• Fine Chemical Synthesis: Acts as a specialized building block for constructing complex natural product analogs and other architecturally intricate molecules.
• Agrochemical Development: Investigated as a potential intermediate for creating new crop protection agents with novel modes of action.

Basic Information

Item	Details
Product Name	6,7-Dihydro-4,10,11-Trimethoxy-7-Methyl-5H-Benzo[G]-1,3-Benzodioxolo[6,5,4-De]Quinoline
CAS No.	38366-01-7
Molecular Formula	C22H23NO5
Molecular Weight	381.42 g/mol
Synonyms	7-Methylthalidezine; Thalidezine, 7-methyl-; NSC 339587; 5H-Benzo[g]-1,3-benzodioxolo[6,5,4-de]quinoline, 6,7-dihydro-4,10,11-trimethoxy-7-methyl-; 7-Methyl-thalidezine; 4,10,11-Trimethoxy-7-methyl-6,7-dihydro-5H-benzo[g][1,3]benzodioxolo[6,5,4-de]quinoline
EINECS	Contact for details

Quality Control

Our 6,7-Dihydro-4,10,11-Trimethoxy-7-Methyl-5H-Benzo[G]-1,3-Benzodioxolo[6,5,4-De]Quinoline is produced under strict quality management systems. Every batch undergoes comprehensive analytical characterization to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing purity (typically by HPLC), identity confirmation (by IR, NMR), and impurity profiles are available upon request. We adhere to cGMP principles where applicable to support our clients' regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound is light-sensitive (store away from light). Keep the container tightly sealed in a dry environment to minimize exposure to moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.5%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.